Actinium Pharmaceuticals
ATNM
#9846
Rank
A$64.7 M
Marketcap
A$2.07
Share price
-2.80%
Change (1 day)
0.31%
Change (1 year)

Market capitalization of Actinium Pharmaceuticals (ATNM)

Market cap: A$64.7 Million

As of January 2026 Actinium Pharmaceuticals has a market cap of A$64.7 Million. This makes Actinium Pharmaceuticals the world's 9846th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Actinium Pharmaceuticals from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026A$64.7 M-8.59%
2025A$70.79 M17.63%
2024A$60.18 M-70.56%
2023A$0.20 B-48.75%
2022A$0.39 B117.26%
2021A$0.18 B3.21%
2020A$0.17 B247.29%
2019A$51.21 M-19.43%
2018A$63.56 M-6.56%
2017A$68.02 M0.52%
2016A$67.67 M-65.37%
2015A$0.19 B-9.42%
2014A$0.21 B32.98%
2013A$0.16 B425.35%
2012A$30.87 M2480.16%
2011A$1.19 M

End of Day market cap according to different sources

On Jan 9th, 2026 the market cap of Actinium Pharmaceuticals was reported to be:

A$64.24 Million
by Nasdaq info icon info icon
A$64.7 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Genocea Biosciences
GNCA
A$0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$16.90 B 26,017.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$6.59 B 10,085.88%๐Ÿ‡บ๐Ÿ‡ธ USA